Flow Forward Medical raises additional $1.3M
May 18, 2015 | Bobby Burch
Flow Forward Medical boosted its latest funding round to further develop its device that helps improve outcomes for hemodialysis patients.
The Olathe-based company closed a $1.3 million round of additional Series A financing led by the Kansas Bioscience Authority. Flow Forward previously raised $4.4 million, bringing its total funding raised to date to about $5.7 million.
Flow Forward created the AFE blood pump system, which is designed for temporary use to quickly dilate peripheral veins through flow-mediated vascular remodeling prior to arteriovenous fistula surgery. In addition to mitigating care costs, the device reduces morbidity and mortality in hemodialysis patients.
Flow Forward also announced that it will receive a $225,000 Phase I Small Business Innovation Research grant from the National Institutes of Health. The grant will help fund testing on peripheral vein dilation with the AFE System prior to AVF creation in a nonclinical model.
Flow Forward is a spinoff of CEO Nick Franano’s previous company, Novita Therapeutics. To learn more on Flow Forward and its device, click here.
Featured Business
2015 Startups to Watch
stats here
Related Posts on Startland News
New platform GUILDit offers art entrepreneurs visibility
A new program called GUILDit to promote and support art entrepreneurship is coming to Kansas City. The program is a bi-monthly gathering where art entrepreneurs take the stage to give six-minute presentations followed by questions and answers in the hopes of crafting a stronger Kansas City art economy, and to further connections between local artists.…
In time for Mother’s Day: Ovatemp wants to boost women’s fertility
The arrival of Ana Mayer’s baby girl isn’t the only thing she’ll be thinking about this Mother’s Day. Mayer — who’s among the newest founders in the Techstars-led Sprint Mobile Health Accelerator in Kansas City — will also be mulling how to further develop Ovatemp, the Boston-based ovulation tech company she leads. Ovatemp offers women…